Note 2 - Revenue (Tables)

9 Months Ended

Dec. 31, 2025

Notes Tables

Disaggregation of Revenue [Table Text Block]

	Three Months Ended December 31, 2025
	Sterilization and Disinfection Control		Biopharmaceutical Development		Calibration Solutions		Clinical Genomics		Total
Consumables	$	22,357	$	4,880	$	658	$	8,836	$	36,731
Hardware and software		152		6,277		8,904		2,011		17,344
Services		2,405		3,216		4,510		920		11,051
Total revenues	$	24,914	$	14,373	$	14,072	$	11,767	$	65,126

	Three Months Ended December 31, 2024
	Sterilization and Disinfection Control		Biopharmaceutical Development		Calibration Solutions		Clinical Genomics		Total
Consumables	$	20,991	$	4,909	$	1,043	$	9,866	$	36,809
Hardware and software		52		4,534		9,333		1,877		15,796
Services		2,464		2,794		4,053		924		10,235
Total revenues	$	23,507	$	12,237	$	14,429	$	12,667	$	62,840

	Nine Months Ended December 31, 2025
	Sterilization and Disinfection Control		Biopharmaceutical Development		Calibration Solutions		Clinical Genomics		Total
Consumables	$	64,650	$	13,087	$	2,251	$	25,893	$	105,881
Hardware and software		388		17,227		24,008		4,361		45,984
Services		7,393		9,465		13,733		2,950		33,541
Total revenues	$	72,431	$	39,779	$	39,992	$	33,204	$	185,406

	Nine Months Ended December 31, 2024
	Sterilization and Disinfection Control		Biopharmaceutical Development		Calibration Solutions		Clinical Genomics		Total
Consumables	$	60,860	$	12,657	$	2,067	$	26,156	$	101,740
Hardware and software		365		14,539		24,067		6,511		45,482
Services		7,444		8,916		12,358		2,903		31,621
Total revenues	$	68,669	$	36,112	$	38,492	$	35,570	$	178,843

Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]

	Three Months Ended December 31,				Nine Months Ended December 31,
	2025		2024		2025		2024
United States	$	29,892	$	30,476	$	86,838	$	85,415
China		5,645		6,322		16,389		20,271
Other		29,589		26,042		82,179		73,157
Total revenues	$	65,126	$	62,840	$	185,406	$	178,843

Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]

Contract liabilities as of March 31, 2025	$	14,803
Prior year liabilities recognized in revenues during the nine months ended December 31, 2025		(9,366	)
Contract liabilities added during the nine months ended December 31, 2025, net of revenues recognized		9,132
Contract liabilities as of December 31, 2025	$	14,569